Corporate Social Responsibility Report

The report describes Genmab's CSR approach around its patient-focused purpose and four areas: employee well-being, ethics in clinical studies, environment, and business ethics and transparency. It reports 33% female board membership among General Meeting-elected directors and a 59% female share in the Genmab Group workforce. Environmental impacts are described qualitatively, with no environmental indicators included because the impact was considered limited. The report also highlights leadership development, security and GDPR compliance actions, and BREEAM Excellent certification for a new Genmab B.V. facility.